Clazakizumab Terminated Phase 2 Trials for Crohn's Disease (CD) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01545050 | Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease |